Abstract
With the advent of the AIDS pandemic in the last 15 years or so, the number of P. carinii pneumonia (PCP) cases has risen dramatically (1–6), establishing P. carinii pneumonia as the first life-threatening opportunistic infection recognized in AIDS (3–5,7), occuring as the initial manifestation in 50–60% of cases (8–10). It has been estimated that as many as 80% of AIDS patients may develop PCP at least once (11,12).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Coolfont Report. A PHS plan for prevention and control of AIDS and the AIDS virus. Publ. Health Rep., 101, 341, 1986.
Hopewell, P. C. Pneumocystis carinii pneumonia: diagnosis. J. Infect. Dis., 137, 1115, 1988.
Gottlieb, M. S., Schroff, R., Schanker, H. M., et al. Pneumocystis carinii pneumonia and mucosal candiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N. Engl. J. Med., 305, 1425, 1981.
Masur, H., Michelis, M. A., Greene, J. B., et al. An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N. Engl. J. Med., 305, 1431, 1981.
Centers for Disease Control. Pneumocystic pneumonia: Los Angeles. Morbid. Mortal. Wkly Rep., 30, 250, 1981.
Kim, B., Lyons, T. M., Parada, J. P., et al. HIV- related Pneumocystis carinii pneumonia in older patients hospitalized in the early HAART era. J. Gen. Intern. Med., 16, 583–589, 2001 [see also: J. Gen. Intern. Med., 16, 583–589, 2001 ].
Centers for Disease Control. Kaposi’s sarcoma and pneumocystic pneumonia among homosexual men: New York City and California. Morb. Mortal. Wkly Rep., 30, 305, 1981.
Lipschik, G. Y. and Masur, H. Pneumocystis carinii pneumonia (PCP), in Prog. Clin. Parasitol., vol. 2, Sun, T., Ed. Field and Wood, New York, 27, 1991.
Curran, J. W., Morgan, W. M., Hardy, A. M., Jaffe, H. W., Darrow, W. W., and Dowdle, W. R. The epidemiology of AIDS: current status and future prospects. Science, 229, 1352, 1985.
Centers for Disease Control. Update: acquired immunodeficiency syndrome: United States. Morb. Mortal. Wkly Rep., 34, 245, 1985.
Centers for Disease Control. Update: acquired immunodeficiency syndrome: United States. Morb. Mortal. Wkly Rep., 35, 542, 1986.
Murray, J. F., Garay, S. M., Hopewell, P. C., Mills, J., Snider, G. L., and Stover, D. G. NHLBI workshop summary: pulmonary complications of the acquired immune deficiency syndrome: an update. Am. Rev. Respir. Dis., 135, 504, 1987.
Hughes, W. T. Pneumocystis carinii pneumonitis. N. Engl. J. Med., 317, 1021, 1987.
Haron, E., Bodey, G. P., Luna, M. A., Dekmezian, R., and Elting, L. Has the incidence of Pneumocystis carinii pneumonia in cancer patients increased with the AIDS epidemic? Lancet, 2, 904, 1988.
Thaker, H., Snow, M. H., Spickett, G., Griffin, S. M., and Gascoigne, A. Pneumocystis carinii pneumonia after thoracic duct ligation and leakage. Clin. Infect. Dis., 33, E129 — E231, 2001.
Cardenal, R., Medrano, F. J., Varela, J. M., et al. Pneumocystis carinii pneumonia in heart transplant recipients. Eur. J. Cardiothorac. Surg., 20, 799–802, 2001.
Kawamura, T., Sando, Y., Tajima, S., et al. Pulmonary intravascular lymphoma complicated with Pneumocystis carinii pneumonaia: a case report. Jpn. J. Clin. Oncol., 31, 333–336, 2001.
Toledo, A. C., Jr. and de Castro, M. R. Pneumocystis carinii pneumonia, pulmonary tuberculosis and visceral leishmaniasis in an adult HIV negative patient. Braz. J. Infect. Dis., 5, 154–157, 2001.
Fishman, J. A. Prevention of infection caused by Pneumocystis carinii in transplant patients. Clin. Infect. Dis., 33, 1397–1405, 2001.
Groll, A. H., Ritter, J., and Muller, F. M. Guidelines for prevention of Pneumocystis carinii pneumonitis in children and adolescents with cancer. Klin. Padiatr., 213 (Suppl. 1), A38 — A49, 2001.
Dykewicz, C. A., Centers for Disease Control and Prevention (U.S.), Infectious Diseases Society of America, American Society of Blood and Marrow Transplantation. Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Clin. Infect. Dis., 33, 139–144, 2001.
Saito, T., Seo, S., Kanda, Y., et al. Early onset Pneumocystis carinii pneumonia after allogeneic peripheral blood stem cell transplantation. Am. J. Hematol., 67, 206–209, 2001.
Burke, B. A. and Good, R. A. Pneumocystis carinii infection. Medicine (Baltimore), 52, 23, 1973.
Walzer, P. D., Schultz, M. G., Western, K. A., and Robbins, J. B. Pneumocystis carinii pneumonia and primary immune deficiency diseases of infancy and childhood. J. Pediatr., 82, 416, 1973.
Leggiadro, R. J., Winkelstein, J. A., and Hughes, W. T. Prevalence of Pneumocystis carinii pneumonitis in severe combined immunodeficiency. J. Pediatr., 99, 96, 1981.
Rao, C. P. and Gelfand, E. W. Pneumocystis carinii pneumonitis in patients with hypogammaglobulinemia and intact T cell immunity. J. Pediatr., 103, 410, 1983.
Lederman, H. and Winkelstein, J. A. Congenital agammaglobulinemia: the clinical course of 88 patients. Pediatr. Res., 17, 254A, 1983.
Dutz, W., Post, C., Vessai, K., and Kohout, E. Endemic infantile Pneumocystis carinii infection: the Shiraz study. Natl. Cancer Inst. Monogr., 43, 31, 1976.
Hughes, W. T., Price, R. A., Sisko, F., et al. Protein-calorie malnutrition: a host determinant for Pneumocystis carinii pneumonia. Am. J. Dis. Child., 128, 44, 1974.
Tsai, H. C., Lee, S. S., Lin, H. H., Lu, L. Y., and Liu, Y. C. Pneumocystis carinii pneumonia in systemic lupus erythematosus: a report of two cases. J. Formos. Med. Assoc., 100, 699–702, 2001.
Sharma, C. P., Chaudhary, D., and Behera, D. Pneumocystis carinii pneumonia in a patient with active untreated systemic lupus erythematosus. Indian J. Chest Dis. Allied Sci., 43, 169–171, 2001.
Ikawa, H., Hayashi, Y., Ohbayashi, C., Tankawa, H., and Itoh, H. Autopsy case of alcoholic hepatitis and cirrhosis treated with corticosteroids and affected by Pneumocystis carinii and cytomegalovirus pneumonia. Pathol. Int., 51, 629–632, 2001.
Sing, A., Geiger, A. M., Hogardt, M., and Heesemann, J. Pneumocystis carinii carriage among cystic fibrosis patients, as detected by nested PCR. J. Clin. Microbiol., 39, 2717–2718, 2001.
Hughes, W. T. Pneumocystis carinii pneumonia, in Infections and the Compromised Host: Clinical Correlations and Therapeutic Approaches, 2nd ed., Allen, J. C., Ed. Williams and Wilkins, Baltimore, 91, 1981.
Hughes, W. T. Pneumocystis carinii Pneumonitis. CRC Press, Boca Raton, 1987.
Gajdusek, D. C. Pneumocystis carinii: etiologic agent of interstitial plasma cell pneumonia of premature and young infants. Pediatrics, 19, 543, 1957.
Dutz, W., Jennings-Khodadad, E., Post, C., Kohout, E., Nazarian, I., and Esmaili, H. Marasmus and Pneumocystis carinii pneumonia in institutionalized infants. Z. Kinderheilkd., 117, 241, 1974.
Gleason, W. A., Roden, V. J., and Decastro, E. Pneumocystis pneumonia in Vietnamese infants. J. Pediatr., 87, 1001, 1975.
Varthalitis, I. and Meunier, F. Pneumocystis carinii pneumonia in cancer patients. Cancer Treat. Rev., 19, 387, 1993.
Varthalitis, I., Aoun, M., Daneau, D., and Meunier, F. Pneumocystis carinii pneumonia in patients with cancer: an increasing incidence. Cancer, 71, 481, 1993.
Sepkowitz, K. A. Pneumocystis carinii pneumonia among patients with neoplastic disease. Semin. Respir. Dis., 7, 114, 1992.
Hughes, W. T., Sanyal, S. K., and Price, R. A. Signs, symptoms, and pathophysiology of Pneumocystis carinii. Natl. Cancer Inst. Monogr., 43, 77, 1976.
Lipson, A., Marshall, W. C., and Hayward, A. R. Treatment of Pneumocystis carinii in children. Arch. Dis. Child., 52, 314, 1977.
Bernstein, C. N., Kolodny, M., Block, E., and Shanahan, F. Pneumocystis carinii pneumonia in patients with ulcerative colitis treated with corticosteroids. Am. J. Gastroenterol., 88, 574, 1993.
Liam, C. K. and Wang, F. Pneumocystis carinii pneumonia in patients with systemic lupus erythematosus. Lupus, 1, 379, 1992.
Tuan, I. Z., Dennison, D., and Weisdorf, D. J. Pneumocystis carinii pneumonitis followed bone marrow transplantation. Bone Marrow Transplant., 10, 267, 1992.
Lim, K. L., Powell, R. J., and Johnston, I. D. Pneumocystis carinii pneumonia following immunosuppressive therapy in systemic lupus erythematosus. Br. J. Rheumatol., 31, 643, 1992.
Porter, D. R., Marshall, D. A. S., Madhok, R., Capell, H., and Sturrock, R. D. Pneumocystis carinii infection complicating cytotoxic therapy in two patients with lymphopenia, but a normal total white cell count. Br. J. Rheumatol., 31, 71, 1992.
Kingsmore, S. F. and Schwab, S. J. Pneumonia due to Pneumocystis carinii in a transplant recipient with normal arterial oxygen tension and normal radiographic findings. South. Med. J., 86, 1052, 1993.
Epstein, L. J., Meyer, R. D., Antonson, S., Strigle, S. M., and Mohsenifar, Z. Persistence of Pneumocystis carinii in patients with AIDS receiving chemoprophylaxis. Am. J. Respir. Crit. Care Med., 150 (5 Part 1), 1456, 1994.
Knox, D. L. and Green, W. R. Pneumocystis carinii granuloma of the optic nerve: a histopathologic case report. J. Neuroophthalmol., 21, 274–275, 2001.
Miller, R. F., Ambrose, H. E., and Wakefield, A. E. Pneumocystis carinii f. sp. hominis DNA in immunocompetent health care workers in contact with patients with P. carinii pneumonia. J. Clin. Microbiol., 39, 3877–3882, 2001.
Kovacs, J. A., Hiemenz, J. W., Macher, A. M., et al. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann. Intern. Med., 100, 663, 1984.
Safrin, S. Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Semin. Respir. Med., 8, 96, 1993.
Sterling, R. P., Bradley, B. B., Khalil, K. G., Kerman, R. H., and Conklin, R. H. Comparison of biopsy-proven Pneumocystis carinii pneumonia in acquired immune deficiency syndrome patients and renal allograft recipients. Ann. Thorac. Surg., 38, 494, 1984.
Haverkos, H. W. Assessment of therapy for Pneumocystis carinii pneumonia: PCP therapy project group. Am. J. Med., 76, 501, 1984.
Staikowsky, F., Lafon, B., Guidet, B., Denis, M., Mayaud, C., and Offenstadt, G. Mechanical ventilation for Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Chest, 104, 756, 1993.
Ahmad, H., Mehta, N. J., Manikal, V. M., et al. Pneumocystis carinii pneumonia in pregnancy. Chest, 120, 666–671, 2001.
Ognibene, F. P., Shelhamer, J. H., Hoffman, G. S., et al. Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener’s granulomatosis. Am. J. Respir. Crit. Care Med., 151 (3 part 1), 795, 1995.
Jarrousse, B., Guillevin, L., Bindi, P., et al. Increased risk of Pneumocystis carinii pneumonia in patients with Wegener’s granulomatosis. Clin. Exp. Rheumatol., 11, 615, 1993 [published erratum appeared in Clin. Exp. Rheumatol., 12, 117, 1994 ].
Abernathy-Carver, K. J., Fan, L. L., Boguniewicz, M., Larsen, G. L., and Leung, D. Y. Legionella and Pneumocystis pneumonias in asthmatic children on high doses of systemic steroids. Pediatr. Pulmonol., 18, 135, 1994.
Smulian, A. G. Pneumocystis carinii: genetic diversity and cell biology. Fungal Genet. Biol., 34, 145–154, 2001.
Volpe, G., Sbaiz, L., Avanzini, C., Caramello, P., and Savoia, D. Genetic diversity of Pneumocystis carinii isolated from human immunodeficiency virus-positive patients in Turin, Italy. J. Clin. Microbiol., 39, 2995–2997, 2001.
Ambrose, H. E., Ponce, C. A., Wakefield, A. E., Miller, R. F., and Vargas, S. L. Distribution of Pneumocystis carinii f. sp. hominis types in the lung of a child dying of Pneumocystis carinii. Clin. Infect. Dis., 33, eí00-e102, 2001.
Helweg-Larsen, J., Lundgren, B., and Lundgren, J. D. Heterogeneity and compartmentalization of Pneumocystis carinii. J. Clin. Microbiol., 39, 3789–3792, 2001.
Navin, T. R., Beard, C. B., Huang, L., et al. Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P. carinii pneumonia in patients with HIV-1: a prospective stidy. Lancet, 358, 545–549, 2001.
Woodward, S. C. and Sheldon, W. H. Subclinical Pneumocystis carinii pneumonitis in adults. Bull. Johns Hopkins Hosp., 109, 148, 1961.
Hamlin, W. B. Pneumocystis carinii. J. Am. Med. Assoc., 204, 171, 1968.
Esterly, J. A. Pneumocystis carinii in lungs of adults at autopsy. Am. Rev. Respir. Dis., 97, 935, 1968.
Meuwissen, J. H., Tauber, I., Leeuwenberg, A. D., Beckers, P. J., and Sieben, M. Parasitologic and serologic observations of infection with pneumocystis in humans. J. Infect. Dis., 136, 43, 1977.
Pifer, L. L., Hughes, W. T., Stagno, S., and Woods, D. Pneumocystis carinii infection: evidence for high prevalence in normal and immunosuppressed children. Pediatrics, 61, 35, 1978.
Kovacs, J. A., Halpern, J. L., Swan, J. C., Moss, J., Parrillo, J. E., and Masur, H. Identification of antigens and antibodies specific for Pneumocystis carinii. J. Immunol., 140, 2023, 1988.
Smith, D. E., McLuckie, A., Wyatt, J., and Gazzard, B. Severe exercise hypoxaemia with normal or near-normal x-rays: a feature of Pneumocystis carinii infection. Lancet, 2, 1049, 1988.
Israel, H. L., Gottlieb, J. E., and Schulman, E. S. Hypoxemia with normal chest roentgenogram due to Pneumocystis carinii pneumonia: diagnostic errors due to a low suspicion of AIDS. Chest, 92, 857, 1987.
Kennedy, C. A. and Goetz, M. B. Atypical roentgenographic manifestations of Pneumocystis carinii pneumonia. Arch. Intern. Med., 152, 1390, 1992.
Peters, J. W. and Sattler, F. R. Atypical Pneumocystis carinii pneumonia: the potential hazards of empiric treatment. South. Med. J., 76, 800, 1983.
Cross, A. S. and Steigbigel, R. T. Pneumocystis carinii pneumonia presenting as localized nodular densities. N. Engl. J. Med., 291, 831, 1974.
Hartz, J. W., Geisinger, K. R., Scharyj, M., and Muss, H. B. Granulomatous pneumocystosis presenting as a solitary pulmonary nodule. Arch. Pathol. Lab. Med., 109, 466, 1985.
Barrio, J. L., Suarez, M., Rodriguez, J. L., Saldana, M. J., and Pitchenik, A. E. Pneumocystis carinii pneumonia presenting as cavitating and noncavitating solitary pulmonary nodules in patients with the acquired immunodeficiency syndrome. Am. Rev. Respir. Dis., 134, 1094, 1986.
Bleiweiss, I. J., Jagirdar, J. S., Klein, M. J., et al. Granulomatous Pneumocystis carinii pneumonia in three patients with the acquired immune deficiency syndrome. Chest, 94, 580, 1986.
Byrd, R. B. and Horn, B. R. Infection due to Pneumocystis carinii stimulating lobar bacterial pneumonia. Chest, 70, 91, 1976.
Stokes, D. C., Shenep, J. L., Horowitz, M. E., and Hughes, W. T. Presentation of Pneumocystis carinii pneumonia as unilateral hyperlucent lung. Chest, 94, 201, 1988.
Abd, A. G., Nierman, D. M., Ilowite, J. S., Pierson, R. N. Jr., and Bell, A. L. Jr. Bilateral upper lobe Pneumocystis carinii pneumonia in a patient receiving inhaled pentamidine prophylaxis. Chest, 94, 329, 1988.
Oki, Y., Kami, M., Kishi, Y., et al. Pneumocystis carinii pneumonia with an atypical granulomatous response in a patient with chronic lymphocytic leukemia. Leuk. Lymphoma, 41, 435–438, 2001.
Albrecht, H., Stellbrink, H. J., Fenske, S., Koch, J., and Greten, H. A novel variety of atypical Pneumocystis carinii infection after long-term prophylactic pentamidine inhalation in an AIDS patient. Clin. Invest., 71, 310, 1993.
Srivatsa, S. S., Burger, C. D., and Douglas, W. W. Upper lobe pulmonary parenchymal calcification in a patient with AIDS and Pneumocystis carinii pneumonia receiving aerosolized pentamidine. Chest, 101, 266, 1992.
Anderson, C. D. and Barrie, B. M. Fatal Pneumocystis pneumonia in an adult. Am. J. Clin. Pathol., 34, 365, 1960.
Livingstone, C. B. Pneumocystis pneumonia occuring in a family with agammaglobulinemia. Can. Med. Assoc. J., 90, 1223, 1964.
Sundar, K., Rosado-Santos, H., Reimer, L., Murray, K., and Michael, J. Unusual presentation of thoracic Pneumocystis carinii infection in a patient with acquired immunodeficiency syndrome. Clin. Infect. Dis., 32, 498–501, 2001.
Barnett, R. N., Hull, J. G., Vortel, V., and Schwartz, J. Pneumocystis carinii in lymph nodes and spleen. Arch. Pathol., 88, 175, 1969.
Awen, C. F. and Baltzan, M. A. Systemic dissemination of Pneumocystis carinii pneumonia. Can. Med. Assoc. J., 104, 809, 1971.
Roder, V. H. and Kleine-Natrop, H. E. Morphologischer zufallsbefund von Pneumocystis carinii in stromenden blut bei erythema nodosum. Derm. Mschr., 157, 678, 1971.
LeGolvan, D. P. and Heidelberger, K. P. Disseminated granulomatous Pneumocystis carinii pneumonia. Arch. Pathol., 95, 344, 1973.
Price, R. A. and Hughes, W. T. Histopathology of Pneumocystis carinii infestation and infection in malignant disease in childhood. Hum. Pathol., 5, 737, 1974.
Rahimi, S. A. Disseminated Pneumocystis carinii in thymic alymphoplasia. Arch. Pathol., 97, 162, 1974.
Henderson, D. W., Humeniuk, V., Meadows, R., and Forbes, I. J. Pneumocystis carinii pneumonia with vascular and lymph nodal involvement. Pathology, 6, 235, 1974.
Kwok, S., O’Donnell, J. J., and Wood, I. S. Retinal cotton-wool spots in a patient with Pneumocystis carinii infection. N. Engl. J. Med., 307, 184, 1982.
Rossi, J. F., Dubois, A., Bengler, C., et al. Pneumocystis carinii in bone marrow. Ann. Intern. Med., 102, 868, 1985.
Delage, A., Bengler, C., Ross, J. F., Marin, J., and Lauraine, M. C. Pneumocystis carinii dans la moelle osseuse. Bull. Soc. Path. E., 78, 478, 1985.
Coulman, C. U., Greene, I., and Archibald, R. W. Cutaneous pneumocystosis. Ann. Intern. Med., 106, 396, 1987.
Grimes, M. M., LaPook, J. D., Bar, M. H., Wasserman, H. S., and Dwork, A. Disseminated Pneumocystis carinii infection in a patient with acquired immunodeficiency syndrome. Hum. Pathol., 18, 307, 1987.
Schinella, R. A., Breda, S. D., and Hammerschlag, P. E. Otic infection due to Pneumocystis carinii in an apparently healthy man with antibody to the human immunodeficiency virus. Ann. Intern. Med., 106, 399, 1987.
Macher, A. M., Bardenstein, D. S., Zimmerman, L. E., et al. Pneumocystis carinii chorioditis in a male homosexual with AIDS and disseminated pulmonary and extrapulmonary P. carinii infection. N. Engl. J. Med., 316, 1092, 1987.
Pilon, V. A., Echols, R. M., Celo, J. S., and Elmendorf, S. L. Disseminated Pneumocystis carinii infection in AIDS. N. Engl. J. Med., 316, 1410, 1987.
Steigman, C. K., Pastore, L., Park, C. H., et al. Case for diagnosis: AIDS. Milit. Med., 152, Ml, 1987.
Carter, T. R., Cooper, P. H., Petri, W. A. Jr., Kim, C. K., Walzer, P. D., and Guerrant, R. L. Pneumocystis carinii infection of the small intestine in a patient with acquired immune deficiency. Am. J. Clin. Pathol., 89, 79, 1988.
Gallant, J. E., Enriquez, R. E., Cohen, K. L., and Hammers, L. W. Pneumocystis carinii thyroiditis. Am. J. Med., 84, 303, 1988.
Gherman, C. R., Ward, R. R., and Bassis, M. L. Pneumocystis carinii otitis and mastoiditis as the initial manifestation of the acquired immunodeficiency syndrome. Am. J. Med., 85, 250, 1988.
Patel, S. K., Philpott, J. M., and McPartlin, D. W. An unusual case of Pneumocystis carinii presenting as an aural mass. J. Laryngol. Otol., 113, 555–557, 1999.
Unger, P. D., Rosenblum, M., and Krown, S. E. Disseminated Pneumocystis carinii infection in a patient with acquired immunodeficiency syndrome. Hum. Pathol., 19, 113, 1988.
Hagman, S., Merall, S., Sitnitskaya, Y., Fefferman, N., and Pollack, H. Pneumocystis carinii infection presenting as an intra-abdominal cystic mass in a child with acquired immunodeficiency syndrome. Clin. Infect. Dis., 33, 1424–1426, 2001.
Dugel, P. V., Rao, N. A., Forster, D. J., Chong, L. P., Frangieh, G. T., and Sattler, F. Pneumocystis carinii choroiditis after long-term aerosolized pentamidine therapy. Am. J. Ophthalmol., 110, 113, 1990.
Rao, N. A., Zimmerman, P. L., Boyer, D., et al. A clinical, histopathologic and electron microscopic study of Pneumocystis carinii choroiditis. Am. J. Ophthalmol., 107, 218, 1989.
Lalonde, L., Allaire, G. S., Sebag, M., Lamer, L., Marcil, G., and Gervais, A. Pneumocystis carinii choroidopathy and aerosolized pentamidine prophylaxis in a patient with AIDS. Can. J. Ophthalmol., 28, 291, 1993.
Freeman, W. R., Gross, J. G., Labelle, J., Oteken, K., Katz, B., and Wiley, C. A. Pneumocystis carinii choroidopathy, a new clinical entry. Arch. Ophthalmol., 107, 863, 1989.
Armstrong, D. and Bernard, E. Aerosol pentamidine. Ann. Intern. Med., 109, 852, 1988.
Hagopian, W. A. and Huseby, J. S. Pneumocystis hepatitis and choroiditis despite successful aerosolized pentamidine pulmonary prophylaxis. Chest, 96, 949, 1989.
Smith, M. A., Hirschfield, L. S., Zahtz, G., and Siejal, F. P. Pneumocystis carinii otitis media. Am. J. Med., 85, 745, 1988.
Breda, S. D., Gigliotti, F., Hammerschlag, P. E., and Schinella, R. Pneumocystis carinii in the temporal bone as a primary manifestation to the acquired immunodeficiency syndrome. Ann. Otol. Rhinol. Laryngol., 97, 427, 1988.
Sandler, E. D., Sandler, J. M., LeBoit, P. E., Wenig, B. M., and Mortensen, N. Pneumocystis carinii otitis media in AIDS: a case report and review of the literature regarding extrapulmonary pneumocystosis. Otolaryngol. Head Neck Surg., 103, 817, 1990.
Patey, O., Salvanet, A., Serrhini, A., and Lafaix, C. Pneumocystis carinii in AIDS patients. AIDS, 7, 1015, 1993.
Sha, B. E., Benson, C. A., Deutsch, T., et al. Pneumocystis carinii chorioditis in patients with AIDS: clinical features, response to therapy, and outcome. J. Acquir. Immune Defic. Syndr., 5, 1051, 1992.
Edman, U., Edman, J. C., and Santi, D. Isolation and expression of the Pneumocystis carinii thymidate synthase gene. Proc. Natl. Acad. Sci. USA, 86, 6503, 1989.
Drucker, D. J., Bailey, D., and Rotstein, L. Thyroiditis as the presenting manifestation of disseminated extrapulmonary Pneumocystis carinii infection. J. Clin. Endocrinol. Metab., 71, 1663, 1990.
Delorenzo, L. J., Huang, C. T., Maguire, G. P., and Stone, D. J. Roentgenographic patterns of Pneumocystis carinii pneumonia in 104 patients with AIDS. Chest, 91, 323, 1987.
Dyner, T. S., Lang, W., Busch, D. F., and Gordon, P. R. Intravascular and pleural involvement by Pneumocystis carinii in a patient with AIDS. Ann. Intern. Med., 111, 94, 1989.
Mariuz, P., Raviglione, M. C., Gould, I. A., and Mullen, M. P. Pleural Pneumocystis carinii infection. Chest, 99, 774, 1991.
Telzak, E. E., Cote, R. J., Gold, J. W. M., Campbell, S. W., and Armstrong, D. Extrapulmonary Pneumocystis carinii infections. Rev. Infect. Dis., 12, 380, 1990.
Witt, K., Nielsen, T. N., and Junge, J. Dissemination of Pneumocystis carinii in patients with AIDS. Scand. J. Infect. Dis., 23, 691, 1991.
Hennessey, N. P., Parro, E. L., and Cockerell, C. J. Cutaneous Pneumocystis carinii infection in patients with acquired immunodeficiency syndrome. Arch. Dermatol., 127, 1699, 1991.
Lecuit, M., Livartowski, J., Vons, C., et al. Resistance to trimethoprim-sulfamethoxazole and sensitivity to pentamidine therapy in an AIDS patient with hepatosplenic pneumocystosis. AIDS, 8, 1506, 1994.
Northfelt, D., Michael, J., and Safrin, J. Extrapulmonary pneumocystosis: clinical features in human immunodeficiency infection. Medicine (Baltimore), 89, 392, 1990.
Bazin, C., Hazera, P., Greder, A., et al. Extrapulmonary disseminated pneumocystosis in HIV infection. Presse Med., 22, 161, 1993.
Raviglione, M. C. Extrapulmonary pneumocystosis: the first 50 years. Rev. Infect. Dis., 12, 1127, 1990.
Poblete, R. B., Rodriguez, K., Foust, R. T., Reddy, K. R., and Saldana, M. J. Pneumocystis carinii hepatitis in the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med., 110, 737, 1989.
Jarnum, S., Rasmussen, E. F., Ohlsen, A. S., and Sorensen, A. W. Generalized Pneumocystis carinii infection with severe idiopathic hypoproteinemia. Ann. Intern. Med., 68, 138, 1968.
Agarwal, J., Agarwal, G., Ayyagari, A., Kar, D. K., Mishra, S. K., and Bhatia, E. Isolated Pneumocystis carinii infection of adrenal glands causing Addison’s disease in a non-immunocompromised adult. Endocr. Pathol., 12, 87–91, 2001.
Tugwell, P., Bennett, K., and Gent, M. Methotrexate in rheumatoid arthritis. Ann. Intern. Med., 107, 418, 1987.
Perruquet, J. L., Harrington, T. M., and Davis, D. E. Pneumocystis carinii pneumonia following methotrexate therapy for rheumatoid arthritis. Arthritis Rheum., 26, 1291, 1983.
Seideman, P., Müller-Suur, R., and Ekman, E. Renal effect of low dose methotrexate in rheumatoid arthritis. J. Rheumatol., 20, 1126, 1993.
Marshall, D., Sturrock, R. D., Porter, D., and Capell, H. A. Pneumocystis carinii complicating low dose methotrexate treatment for rheumatoid arthritis. Thorax, 47, 67, 1992.
Kane, G. C., Troshinsky, M. B., Peters, S. P., and Israel, H. L. Pneumocystis carinii pneumonia associated with weekly methotrexate: cumulative dose of methotrexate and low CD4 cell count may predict this complication. Respir. Med., 87, 153, 1993.
Krebs, S. and Gibbons, R. B. Low-dose methotrexate as a risk factor for Pneumocystis carinii. Mil. Med., 161, 58–60, 1996.
Leff, R. L., Case, J. P., and McKenzie, R. Rheumatoid arthritis, methotrexate therapy, and Pneumocystis carinii. Ann. Intern. Med., 112, 716, 1990.
Wollner, A., Mohle-Boetani, J., Lambert, R. E., Perruquet, J. L., Raffin, T. A., and Mcguire, J. L. Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for rheumatoid arthritis. Thorax, 46, 205, 1991.
Wallis, P. J. W., Ryatt, K. S., and Constable, T. J. Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for psoriatic arthropathy. Ann. Rheum. Dis., 48, 247, 1989.
Olson, N. J., Callahan, L. F., and Pincus, T. Immunologic studies of rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum., 30, 481, 1987.
Dawson, T., Ryan, P. F. J., Findeisen, J. M., and Scheinkestel, C. D. Pneumocystis carinii pneumonia following cyclosporine A and methotrexate treated rheumatoid arthritis. J. Rheumatol., 19, 997, 1992.
Powles, A. V., Baker, B. S., and Fry, L. Cyclosporine toxicity. Lancet, 335, 610, 1990.
Hammoudeh, M., Siam, A.-R., and Khanjar, I. Renal effect of low dose methotrexate in rheumatoid arthritis. J. Rheumatol., 21, 1168, 1994.
Schneider, M. M. E., Hoepelman, A. I. M., Eeftinck Schattenkerk, J. K., et al. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. N. Engl. J. Med., 327, 1836, 1992.
Calabrese, L. H., Taylor, J. V., Wilke, W. S., Segal, A. M., Valenzuela, R., and Clough, J. D. Response of immunoregulatory lymphocyte subsets to methotrexate in rheumatoid arthritis. Cleve. Clin. J. Med., 57, 232, 1990.
Houtman, P. M., Stenger, A. A. M. E., Bruyn, G. A. W., and Mulder, J. Methotrexate may affect certain T lymphocyte subsets in rheumatoid arthritis resulting in susceptibility to Pneumocystis carinii infection. J. Rheumatol., 21, 1168, 1994.
Sohen, S., Kita, H., and Tanaka, S. Abnormalities in bone marrow mononuclear cells in patients with rheumatoid arthritis. J. Rheumatol., 20, 12, 1993.
Gibbons, J. J. and Lucas, J. Immunomodulation by low dose methotrexate. I. Methotrexate selectively inhibits Lyt-2’ cells in murine graft-versus-host reactions. J. Immunol., 142, 1867, 1989.
Fischl, M. A., Richman, D. D., Grieco, M. H., et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial. N. Engl. J. Med., 317, 185, 1987.
Fischl, M. A., Dickinson, G. M., and La Voie, L. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. J. Am. Med. Assoc., 259, 1185, 1988.
Davey, R. T. and Masur, H. Recent advances in the diagnosis, treatment and prevention of Pneumocystis carinii pneumonia. Antimicrob. Agents Chemother., 34, 499, 1990.
Graham, N. M., Zeger, S. L., Park, L. P., et al. Effect of zidovudine and Pneumocystis carinii prophylaxis on progression of HIV-1 infection to AIDS. Lancet, 338, 265, 1991.
Gearhart, M. O. and Bhutani, M. S. Intravenous pentamidine-induced bronchospasm. Chest, 102, 1891, 1992.
Efferen, L. S., Nabarajah, D., and Palat, D. S. Survival following mechanical ventilation for Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome: a different perspective. Am. J. Med., 87, 401, 1989.
El-Sadr, W. and Simberkoff, M. S. Survival and prognostic factors in severe Pneumocystis carinii pneumonia requiring mechanical ventilation. Am. Rev. Respir. Dis., 137, 1264, 1988.
Brenner, M., Ognibene, F. P., Lack, E. E., et al. Prognostic factors and life expectancy of patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Am. Rev. Respir. Dis., 136, 1199, 1987.
Thibert, J., Gasparini, A., Diaz-Mitoma, F., et al., Tolerance of oral trimethoprim-sulfamethoxazole (TMP-SMX) prophylaxis of Pneumocystis carinii pneumonia (PCP). Proc. 9th Int. Conf. AIDS, Berlin, abstract PO-B09–1397, 368, 1993.
Siegel, S. E., Wolff, L. J., Baehner, R. L., and Hammond, D. Treatment of Pneumocystis carinii pneumonitis: a comparative trial of sulfamethoxazole-trimethoprim vs. pentamidine in pediatric patients with cancer: report from the Children’s Cancer Study Center. Am. J. Dis. Child., 138, 1051, 1984.
Vöhringer, H.-F. and Arastéh, K. Pharmacokinetic optimisation in the treatment of Pneumocystis carinii pneumonia. Clin. Pharmacokinet., 24, 388, 1993.
Wharton, J. M., Coleman, D. L., Wofsy, C. B., et al. Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann. Intern. Med., 105, 37, 1986.
Gordin, F. M., Simon, G. L., Wofsy, C. B., and Mills, J. Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann. Intern. Med., 100, 495, 1984.
Masur, H. and Kovacs, J. A. Treatment and prophylaxis of Pneumocystis carinii pneumonia. Infect. Dis. Clin. North Am., 2, 419, 1988.
Hughes, W. T., Feldman, S., Chaudhary, S. C., Ossi, M. J., Cox, F., and Sanyal, S. K. Comparison of pentamidine isethionate and trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia. J. Pediatr., 92, 285, 1978.
Jaffe, H. S., Abrams, D. I., Ammann, A. J., Lewis, B. J., and Golden, J. A. Complications of co-trimoxazole in treatment of AIDS-associated Pneumocystis carinii pneumonia in homosexual men. Lancet, 2, 1109, 1983.
Hughes, W. T., Feldman, S., and Sanyal, S. K. Treatment of Pneumocystis carinii pneumonitis with trimethoprimsulfamethoxazole. Can. Med. Assoc. J., 112, 47, 1975.
Hughes, W. T., Kuhn, S., Chaudhary, S., et al. Successful chemoprophylaxis for Pneumocystis carinii pneumonia. N. Engl. J. Med., 297, 1419, 1977.
Wolff, L. J. and Baehner, R. L. Delayed development of pneumocystis pneumonia following administration of short-term high-dose trimethoprim-sulfamethoxazole. Am. J. Dis. Child., 132, 525, 1978.
Chusid, M. J. and Heyrman, B. A. An outbreak of Pneumocystis carinii pneumonia at a pediatric hospital. Pediatrics, 62, 1031, 1978.
Harris, R. E., McCallister, J. A., Allen, S. A., Barton, A. S., and Baehner, R. L. Prevention of pneumocystis pneumonia: use of continuous sulfamethoxazole-trimethoprim therapy. Am. J. Dis. Child., 134, 35, 1980.
Wilber, R. B., Feldman, S., Malone, W. J., Ryan, M., Aur, R. J., and Hughes, W. T. Chemoprophylaxis for Pneumocystis carinii: outcome of unstructured delivery. Am. J. Dis. Child., 134, 643, 1980.
Perrone, C., Bricaire, F., Leport, C., Assan, D., Vildé, J. L., and Assan, R. Hypoglycaemia and diabetes mellitus following parenteral pentamidine mesylate treatment in AIDS patients. Diabet. Med., 7, 585, 1990.
Kovacs, J. A. and Masur, H. Pneumocystis carinii pneumonia: therapy and prophylaxis. J. Infect. Dis., 158, 254, 1988.
Ivady, G. and Paldy, L. Ein neves behandlungsverfahren der interstitiellen plasmazelligen pneumonie fruhgeborener mit fünfwerigen stibium und aromatischen diamidien. Monatsschr. Kinderheilkd., 106, 10, 1958.
Mallory, D. L., Parrillo, J. E., Bailey, K. R., et al. Cardiovascular effects and safety of intravenous and intramuscular pentamidine isethionate. Crit. Care Med., 15, 503, 1987.
Conte, J. E., Hollander, H., and Golden, J. Inhaled or reduced-dose intravenous pentamidine for Pneumocystis carinii pneumonia. Ann. Intern. Med., 107, 495, 1987.
Sattler, F. R. and Feinberg, J. New development in the treatment of Pneumocystis carinii pneumonia. Chest, 101, 451, 1992.
Monk, J. P. and Benfield, P. Inhaled pentamidine: an overview of its properties and a review of its therapeutic use in Pneumocystis carinii pneumonia. Drugs, 39, 741, 1990.
Navin, T. R. and Fontaine, R. E. Intravenous versus intramuscular administration of pentamidine. N. Engl. J. Med., 311, 1701, 1984.
Montgomery, A. B., Debs, R. J., Luce, J. M., et al. Aerosolized pentamidine as sole therapy for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Lancet, 2, 480, 1987.
O’Doherty, M. J., Thomas, S., Page, C., et al. Diferrences in relative efficacy of nebulizers for pentamidine administration. Lancet, 2, 1283, 1988.
Armstrong, D. and Bernard, E. Aerosol pentamidine. Ann. Intern. Med., 109, 852, 1988.
Yamamoto, H., Koizumi, T., Miyahara, T., Kaneki, T., and Kubo, K. Serial pentamidine levels in bronchial epithelial lining fluid after aerosol administration. Respiration, 68, 506–508, 2001.
Klein, N. C., Duncanson, F. P., Lenox, T. H., et al. Trimethoprim-sulfamethoxazole versus pentamidine for Pneumocystis carinii pneumonia in AIDS patients: results of a large prospective randomized treatment trial. AIDS, 6, 301, 1992.
Lentino, J. R. and Brooks, D. Pneumocystis carinii pneumonia and tuberculosis in a human immunodeficiency virusseronegative patient without evidence of the idiopathic CD4+ T lymphopenia syndrome. Clin. Infect. Dis., 18, 470, 1994.
Smith, D. K., Neal, J. J., and Holinberg, S. D. Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection: an investigation of cases in the United States. The Centers for Disease Control Idiopatic CD4+ T-lymphocytopenia Task Force. N. Engl. J. Med., 328, 373, 1993.
Tijhuis, G. J., Huisman, H. G., and Kauffmann, R. H. AIDS without detectable HIV: a case report. Am. J. Med., 94, 442, 1993.
Lawrence, J. T-cell subsets in health, infectious disease, and idiopathic CD4+ T lymphopenia. Ann. Intern. Med., 119, 55, 1993.
World Health Organization. Unexplained severe immunosuppression without incidence of HIV infection. WHO Wkly Epidem. Rec., 42, 309, 1992.
Jayes, R. L., Kamerow, H. N., Hasselquist, S. M., Delaney, M. D., and Parenti, D. M. Disseminated pneumocystosis presenting as a pleural effusion. Chest, 103, 306, 1993.
Price, D. A., Hollings, N. P., Janes, S. M., Main, J., and Coker, R. J. Clinical response to the addition of clarithromycin in Pneumocystis carinii pneumonia refractory to high dose co-trimoxazole. J. Antimicrob. Chemother., 34, 303, 1994.
Hughes, W. T. The role of atovaquone tablets in treating Pneumocystis carinii pneumonia. J. Acquir. Immune Defic. Syndr. Human Retrovirol., 8, 247, 1995.
Falloon, J., Kovacs, J., Hughes, W., et al. A preliminary evaluation of 566C80 for the treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med., 325, 1534, 1991.
Hughes, W., Leoung, G., Kramer, F., et al. Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS. N. Engl. J. Med., 328, 1521, 1993.
Dohn, M. N., Weinberg, W. G., Tones, R. A., et al. Oral atovaquone compared with intravenous pentamidine for Pneumocystis carinii pneumonia in patients with AIDS. Ann. Intern. Med., 121, 174, 1994.
Lieberman, M. M., van der Horst, C., Stoeckle, M., and Tennenberg, A. Atovaquone for Pneumocystis carinii pneumonia. Ann. Intern. Med., 122, 314, 1995.
Masur, H. Prevention and treatment of Pneumocystis carinii. N. Engl. J. Med., 327, 1853, 1992.
Ashar, N., Daneshvar, H., and Beall, G. Desensitization to trimethoprim-sulfamethoxazole in HIV-infected patients. J. Allergy Clin. Immunol., 93, 1001, 1994.
Leoung, G. S., Mills, J., Hopewell, P. C., Hughes, W., and Wofsy, C. Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficency syndrome. Ann. Intern. Med., 105, 45, 1986.
Kovacs, J. A., Allegra, C. J., Beaver, J., Boarman, D., and Lewis, M. Characterization of de novo folate synthesis in Pneumocystis carinii and Toxoplasma gondii: potential for screening therapeutic agents. J. Infect. Dis., 160, 312, 1989.
Kovacs, J. A., Powell, F., Voeller, D., and Allegra, C. J. Inhibition of Pneumocystis carinii dihydropteroate synthetase by para-acetamidobenzoic acid: possible mechanism of action of isoprinosine in human immunodeficiency virus infection. Antimicrob. Agents Chemother., 37, 1227, 1993.
Hughes, W. T. and Smith, B. L. Efficacy of diaminodiphenylsulfone and other drugs in murine Pneumocystis carinii pneumonia. Antimicrob. Agents Chemother., 26, 436, 1984.
Mills, J., Leoung, G., Medina, I., Hughes, W., Hopewell, P., and Wofsy, C. Dapsone is ineffective therapy for Pneumocystis pneumonia in patients with AIDS. Clin. Res., 34, 101A, 1986.
Medina, I., Mills, J., Leoung, G., et al. Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: a controlled trial for trimethoprim-sulfamethoxazole versus trimethoprim-dapsone. N. Engl. J. Med., 323, 776, 1990.
Smego, R. A., Jr., Nagar, S., Maloba, B., and Popara, M. A meta-analysis of salvage therapy for Pneumocystis carinii pneumonia. Arch. Intern. Med., 161, 1529–1533, 2001.
Kay, R. and Dubois, R. E. Clindamycin/primaquine therapy and secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS. South. Med. J., 83, 403, 1990.
Toma, E. Clindamycin/primaquine for treatment of Pneumocystis carinii in AIDS. Eur. J. Clin. Microbiol. Infect. Dis., 10, 210, 1991.
Black, J. R., Feinberg, J., Murphy, R. L., Fass, R. J., Carey, J., and Sattler, F. R. Clindamycin and primaquine as primary treatment for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS. Eur. J. Clin. Microbiol. Infect. Dis., 10, 204, 1991.
Ruf, B., Rohde, I., and Pohle, H. D. Efficacy of clindamycin/sulfamethoxazole in primary treatment of Pneumocystis carinii pneumonia. Eur. J. Clin. Microbiol. Infect. Dis., 10, 207, 1991.
Panisko, D. M. and Keystone, J. S. Treatment of malaria - 1990. Drugs, 39, 160, 1990.
Smith, N., Blanshard, C., Smith, D., and Gazzard, B. Toxicity of clindamycin and primaquine treatment of AIDS-related Pneumocystic carinii pneumonia. AIDS, 7, 749, 1993.
Zambrano, D. Clindamycin in the treatment of obstetric and gynecologic infections: a review. Clin. Therapeut., 13, 58, 1991.
Toma, E., Fournier, S., Dumont, M., Bolduc, P., and Deschamps, H. Clindamycin/primaquine versus trimethoprimsulfamethoxazole as primary therapy for Pneumocystis carinii pneumonia in AIDS: a randomized, double-blind pilot trial. Clin. Infect. Dis., 17, 178, 1993.
Noskin, G. A., Murphy, R. L., Black, J. R., and Phair, J. P. Salvage therapy with clindamycin/primaquine for Pneumocystis carinii pneumonia. Clin. Infect. Dis., 14, 183, 1992.
Frenkel, J. K., Good, J. T., and Shultz, J. A. Latent Pneumocystis infection of rats, relapse, and chemotherapy. Lab. Invest., 15, 1559, 1966.
Rifkind, D., Faris, T. D., and Hill, R. B. Jr. Pneumocystis carinii pneumonia: studies on the diagnosis and treatment. Ann. Intern. Med., 65, 943, 1966.
Ruskin, J. and Remington, J. S. The immunocompromised host and infection. 1. Pneumocystis carinii pneumonia. J. Am. Med. Assoc., 202, 96, 1967.
Kirby, H. B., Kenamore, B., and Guckian, J. C. Pneumocystis carinii pneumonia treated with pyrimethamine and sulfadiazine. Ann. Intern. Med., 75, 505, 1971.
Farinas, E. and Quel, J. A. Hypertension and duodenal ulcer associated with Pneumocystis carinii pneumonitis and dysgammaglobulinemia. Ill. J. Med., 139, 138, 1971.
Whisnant, J. K. and Buckley, R. H. Successful therapy of Pneumocystis carinii pneumonia in infants with x-linked immunodeficiency with hyper-IgM. Natl. Cancer Inst. Monogr., 43, 211, 1976.
Young, R. C. and Devita, V. T. Jr. Treatment of Pneumocystis carinii pneumonia: current status of the regimens of pentamidine isethionate and pyrimethamine-sulfadiazine. Natl. Cancer Inst. Monogr., 43, 193, 1976.
Allegra, C. J., Kovacs, J. A., Drake, J. C., Swan, J. C., Chabner, B. A., and Masur, H. Activity of antifolates against Pneumocystis carinii dihydrofolate reductase and identification of a potent new agent. J. Exp. Med., 165, 926, 1987.
Queener, S. F., Bartlett, M. S., Jay, M. A., Durkin, M. M., and Smith, J. W. Activity of lipid-soluble inhibitors of dihydrofolate reductase against Pneumocystis carinii in culture and in rat model of infection. Antimicrob. Agents Chemother., 31, 1323, 1987.
Allegra, C. J., Chabner, B. A., Tuazon, C. U., et al. Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with AIDS. N. Engl. J. Med., 317, 978, 1987.
Amsden, G. W., Kowalsky, S. F., and Morse, G. D. Trimetrexate for Pneumocystis carinii pneumonia in patients with AIDS. Ann. Pharmacother., 26, 218, 1992.
Sattler, F. R., Allegra, C. J., Vergedem, T. D., et al. Trimetrexate-leucovorin dosage evaluation study for treatment of Pneumocystis carinii pneumonia. J. Infect. Dis., 161, 91, 1990.
Grem, J. L., King, S. A., Costanza, M. E., and Brown, T. D. Hypersensitivity reactions to trimetrexate. Invest. New Drugs, 8, 211, 1990.
Golden, J. A., Sjoerdsma, A., and Santi, D. A. Pneumocystis carinii pneumonia treated with alphadifluoromethylornithine: a prospective study among patients with the acquired immunodeficiency syndrome. West. J. Med., 141, 613, 1984.
Neibart, E., Sacks, H. S., Hammer, G., and Hirschman, S. Z. Difluoromethylornithine in the treatment of pneumocystis pneumonia. Proc. 8th Intersci. Conf Antimicrob. Agents Chemother., American Society for Microbiology, Washington, D.C., abstract 224, 1986.
Paulson, Y. J. Gilrian, T. M., Boyle, C. T., Sharma, O. P., and Haseltine, P. N. R. Eflornithine treatment of Pneumocystis carinii pneumonia in patients failing other therapy. Proc. 28th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC, abstract 225, 1986.
Smith, D., Davies, S., Nelson, M., Youle, M., Gleeson, J., and Gazzard, B. Pneumocystis carinii pneumonia treated with eflornithine in AIDS patients resistant to conventional therapy. AIDS, 4, 1019, 1990.
Paulson, Y. J., Gilman, T. M., Heseltine, P. N., Sharma, O. P., and Boylen, C. T. Eflornithine treatment of refractory Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Chest, 101, 67, 1992.
Smith, D. E., Davies, S., Smithson, J., Harding, I., and Gazzard, B. G. Eflornithine versus cotrimoxazole in the treatment of Pneumocystis carinii pneumonia in AIDS patients. AIDS, 6, 1489, 1992.
Bozzette, S. A. The use of corticosteroids in Pneumocystis carinii pneumonia. J. Infect. Dis., 162, 1365, 1990.
Walmsley, S., Salit, I. E., and Brunton, J. The possible role of corticosteroid therapy for Pneumocystis carinii in the acquired immune deficiency syndrome (AIDS). J. Acquir. Immune Defic. Syndr., 1, 354, 1988.
Bozzette, S. A., Sattler, F. R., Chiu, J., et al. A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. N. Engl. J. Med., 323, 1451, 1990.
MacFadden, D. K., Edelson, J. D., and Rebuck, A. S. Pneumocystis carinii pneumonia in the acquired immune deficiency syndrome: response to inadvertent steroid therapy. Can. Med. Assoc. J., 132, 1161, 1985.
Hurley, P., Weikel, C., Temeles, D., Rosenburg, S., and Pearson, R. Unusual remission of Pneumocystis carinii pneumonia in a patient with the acquired immune deficiency syndrome. Am. J. Med., 82, 645, 1987.
Foltzer, M. A., Hannan, S. E., and Kozak, A. J. Pneumocystis pneumonia: response to corticosteroids. J. Am. Med. Assoc., 253, 979, 1985.
Rankin, J. A. and Pella, J. A. Radiographic resolution of Pneumocystis carinii pneumonia in response to corticosteroids therapy. Am. Rev. Resp. Dis., 136, 182, 1987.
El-Sadr, W., Sudhu, G., Diamond, G., et al. High-dose corticosteroids as adjunct therapy in severe Pneumocystis carinii pneumonia. AIDS Res., 2, 349, 1986.
Admundson, D. E., Murray, K. M., Brodine, S., and Oldfield, E. C. High-dose corticosteroid therapy for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. South. Med. J., 82, 711, 1989.
MacFadden, D. K., Hyland, R. H., Inouye, T., Edelson, J. D., Rodriguez, C. H., and Rebuck, S. Corticosteroids as adjunctive therapy in treatment of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Lancet, 1, 1477, 1987.
Mottin, D., Denis, M., Dombret, H., Rossert, J., Mayaud, C. H., and Akoun, G. Role for steroids in treatment of Pneumocystis pneumonia in AIDS. Lancet, 2, 519, 1987.
Montaner, J. S. G. and Ruedy, J. Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med., 113, 14, 1990.
Gagnon, S., Boota, A. M., Fischl, M. A., Baier, H., Kirksey, O. W., and La Voie, L. Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: a double-blind placebo-controlled trial. N. Engl. J. Med., 323, 1440, 1990.
Nielsen, T. L., Eeftinck Schattenkerk, J. K., Jensen, B.N., et al. Adjunctive corticosteroids therapy for Pneumocystis carinii pneumonia in AIDS: a randomized European multicenter open label study. J. Acquir. Immune Defic. Syndr., 5, 726, 1992.
Jeantils, V., Nguyen, G., Bade, F., and Thomas, M. Adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in AIDS. Therapie, 48, 70, 1993.
Sistek, C. J., Wordell, C. J., and Hauptman, S. P. Adjuvant corticosteroid therapy for Pneumocystis carinii pneumonia in AIDS patients. Ann. Pharmacother., 26, 1127, 1992.
LaRocco, A. Jr., Amundson, D. E., Wallace, M. R., Malone, J. L., and Oldfield, E. C. 3rd. Corticosteroids for Pneumocystis carinii pneumonia with acute respiratory failure: experience with rescue therapy. Chest, 102, 892, 1992.
Kaufman, M. B. and DeMuria, D. Corticosteroids in AIDS patients with Pneumocystis carinii pneumonia. Ann. Pharmacother., 26, 932, 1992.
Montaner, J. S., Guillemi, S., Quieffin, J., et al. Oral corticosteroids in patients with mild Pneumocystis carinii pneumonia and the acquired immune deficiency syndrome (AIDS). Tuber. Lung Dis., 74, 173, 1993.
Bentsen, K. D., Nielsen, T. L., Eaftinck Schattenkerk, J. K., Jensen, B. N., and Lundgren, J. D. Serum type III procollagen peptide in patients with Pneumocystis carinii infection: the Copenhagen-Amsterdam PCP-Prednisolone Study Group. Am. Rev. Respir. Dis., 148 (6 Part 1), 1558, 1993.
Huang, Z. B. and Eden, E. Effect of corticosteroids on IL-1 beta and TNF by alveolar macrophages from patients with AIDS and Pneumocystis carinii pneumonia. Chest, 104, 751, 1993.
The National Institute of Health. University of California Expert Panel for Corticosteroids as Adjunctive Therapy for Pneumocystis carinii Pneumonia. Consensus statement on the use of corticosteroids as adjunctive therapy for Pneumocystis pneumonia in the acquired immunodeficiency syndrome. N. Engl. J. Med., 323, 1500, 1990.
Clumeck, N. and Hermans, P. Corticosteroids as adjunctive therapy for Pneumocystis pneumonia in patients with AIDS. N. Engl. J. Med., 324, 1666, 1991.
El-Sadr, W., Milder, J., Capps, L., and Sivapalan, V. Corticosteroids as adjunctive therapy for Pneumocystis pneumonia in patients with AIDS. N. Engl. J. Med., 324, 1667, 1991.
Rahal, J. J. Corticosteroids as adjunctive therapy for Pneumocystis pneumonia in patients with AIDS. N. Engl. J. Med., 324, 1666, 1991.
Hardy, A. M., Wajszczuk, C. P., Suffredini, A. F., Hakala, T. R., and Ho, M. Pneumocystis carinii pneumonia in renal-transplant recipients treated with cyclosporine and steroids. J. Infect. Dis., 149, 143, 1984.
Browne, M. J., Hubbard, S. M., Longo, D. L., et al. Excess prevalence of Pneumocystis carinii pneumonia in patients treated for lymphoma with combination chemotherapy. Ann. Intern. Med., 104, 338, 1986.
Farr, R. W. Pneumocystis carinii pneumania to corticosteroids. South. Med. J., 85, 52, 1992.
Walmsley, S., Levinton, C., Brunton, J., et al. A multicenter randomized double-blind placebo-controlled trial of adjunctive corticosteroids in the treatment of Pneumocystis carinii pneumonia complicating the acquired immune deficiency syndrome. J. Acquir. Immune Defic. Syndr. Human Retrovirol., 8, 348, 1995.
Fischl, M. A., Uttamchandani, R. B., Daikos, G. L., et al. An outbreak of tuberculosis caused by multiple-drug-resistant tuberculosis bacilli among patients with HIV infection. Ann. Intern. Med., 117, 177, 1992.
Gill, P. S., Loureiro, C., Bernstein-Singer, M., Rarick, M. U., Sattler, F., and Levine, A. M. Clinical effect of glucocorticoids on Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med., 110, 937, 1989.
Schulhafer, E. P., Grossman, M. E., Fagin, G., and Bell, K. E. Steroid-induced Kaposi’s sarcoma in a patient with pre-AIDS. Am. J. Med., 82, 313, 1987.
Ueda, K., Goto, Y., Yamazaki, S., and Fujisawa, K. Chronic fatal pneumocystosis in nude mice. Jpn. J. Exp. Med., 47, 475, 1977.
Walzer, P. D., Schnelle, V., Armstrong, D., and Rosen, P. P. Nude mouse: a new experimental model for Pneumocystis carinii infection. Science, 197, 177, 1987.
Waltzer, P. D., LaBine, M., Redington, T. J., and Cushion, M. T. Predisposing factors in Pneumocystis carinii pneumonia: effect of tetracycline, protein malnutrition, and corticosteroids on hosts. Infect. Immun., 46, 747, 1984.
Montaner, J. S. G. and Ruedy, J. Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med., 113, 14, 1990.
Nielsen, T. L., Eeftinck Schattenkerk, J. K., Jensen, B.N., et al. Adjunctive corticosteroids therapy for Pneumocystis carinii pneumonia in AIDS: a randomized European multicenter open label study. J. Acquir. Immune Defic. Syndr., 5, 726, 1992.
Clement, M., Edison, R., Turner, R., et al. Corticosteroid as adjunctive therapy in severe Pneumocystis carinii pneumonia: a prospective, placebo-controlled trial. Am. Rev. Respir. Dis., 139, A250, 1989.
Bozzette, S. A. and Morton, S. C. Reconsidering the use of adjunctive corticosteroids in Pneumocystis pneumonia? J. Acquir. Immune Defic. Syndr. Human Retrovirol., 8, 348, 1995.
Harris, J. E. Improved short-term survival of AIDS patients initially diagnosed with Pneumocystis carinii pneumonia 1984 through 1987. J. Am. Med. Assoc., 263, 397, 1990.
Friedman, Y., Franklin, C., Rackow, E. C., and Weil, M. H. Improved survival in patients with AIDS, Pneumocystis carinii pneumonia, and severe respiratory failure. Chest, 96, 862, 1989.
Marolda, J., Pace, B., Bonforte, R. J., Kotin, N., and Kattan, M. Outcome of mechanical ventilation in children with acquired immunodeficiency syndrome. Pediatr. Pulmonol., 7, 230, 1989.
Bye, M. R., Berstein, L. J., Glaser, J., and Kleid, D. Pneumocystis carinii pneumonia in young children with AIDS. Pediatr. Pulmonol., 9, 251, 1990.
Notterman, D. A., Greenwald, B. M., Di Maio-Hunter, A., Wilkinson, J. D., Krasinski, K., and Borkowsky, W. Outcome after assisted ventilation in children with acquired immunodeficiency syndrome. Crit. Care Med., 18, 18, 1990.
Vernon, D. D., Holzman, B. H., Lewis, P., Scott, G. B., Birriel, J. A., and Scott, M. B. Respiratory failure in children with acquired immunodeficiency syndrome and acquired immunodeficiency syndrome-related complex. Pediatrics, 82, 223, 1988.
Sleasman, J. W., Hemenway, C., Klein, A. S., and Barrett, D. J. Corticosteroids improve survival of children with AIDS and Pneumocystis carinii pneumonia. Am. J. Dis. Child., 147, 30, 1993.
Barone, S. R., Aiuto, L. T., and Krilov, L. R. Increased survival of young infants with Pneumocystis carinii pneumonia and acute respiratory failure with early steroid administration. Clin. Infect. Dis., 19, 212, 1994.
Tilles, S. A. Practical issues in the management of hypersensitivity reactions: sulfonamides. South. Med. J., 94, 817824, 2001.
Waskin, H., Stehr-Green, J. K., Helmick, C. G., and Sattler, F. R. Risk factors for hypoglycemia associated with pentamidine therapy for Pneumocystis pneumonia. J. Am. Med. Assoc., 260, 345, 1988.
McSharry, R. J., Kirsch, C. M., Jensen, W. A., and Kagawa, F. T. Prophylaxis of aerosolized pentamidine-induced bronchospasm: a symptom-based approach. Am. J. Med. Sci., 306, 20, 1993.
Renzi, P. M., Corbeil, C., Chasse, M., Braidy, J., and Matar, N. Bilateral pneumothoraces hasten mortality in AIDS patients receiving secondary prophylaxis with aerosolized pentamidine: association with a lower Dco prior to receiving aerosolized pentamidine. Chest, 102, 491, 1992.
Comtois, R., Pouliot, J., Gervais, A., Vinet, B., and Lemieux, C. High pentamidine levels associated with hypoglycemia and azotemia in a patient with Pneumocystis carinii pneumonia. Diagn. Microbiol. Infect. Dis., 15, 523, 1992.
Comtois, R., Pouliot, J., Vinet, B., Gervais, A., and Lemieux, C. Higher pentamidine levels in AIDS patients with hypoglycemia and azotemia during treatment of Pneumocystis carinii pneumonia. Am. Rev. Respir. Dis., 146, 740, 1992.
Jones, R. S. Jr., Collier-Brown, C., and Suh, B. Localized cutaneous reaction to intravenous pentamidine. Clin. Infect. Dis., 15, 561, 1992.
Klatt, E. C. Pathology of pentamidine-induced pancreatitis. Arch. Pathol. Lab. Med., 116, 162, 1992.
Pouwels, A., Eliaszewicz, M., Larrey, D., et al. Pentamidine-induced acute pancreatitis in a patient with AIDS. J. Clin. Gastroenterol., 12, 457, 1990.
Murphy, R. L., Noskin, G. A., and Ehrenpreis, E. D. Acute pancreatitis associated with aerosolized pentamidine. Am. J. Med., 88 (5N), 53N, 1990.
Balslev, U., Berild, D., and Nielsen, T. L., Cardiac arrest during treatment of Pneumocystis carinii pneumonia with intravenous pentamidine isethionate. Scand. J. Infect. Dis., 24, 111, 1992.
Quadrel, M. A., Atkin, S. H., and Jaker, M. A. Delayed cardiotoxicity during treatment with intravenous pentamidine: two case reports and a review of the literature. Am. Heart J., 123, 1377, 1992.
Balslev, U. and Nielsen, T. L. Adverse effects associated with intravenous pentamidine isethionate as treatment of Pneumocystis carinii pneumonia. Dan. Med. Bull., 39, 366, 1992.
Mani, S., Kocheril, A. G., and Andriole, V. T. Case report: pentamidine and polymorphic ventricular tachycardia revisited. Am. J. Med. Sci., 305, 236, 1993.
Cortese, L. M., Gasser, R. A. Jr., Bjornson, D. C., Dacey, M. J., and Oster, C. N. Prolonged recurrence of pentamidineinduced torsades de pointes. Ann. Pharmacother., 26, 1365, 1992.
Warton, J. M., Demopulos, P. A., and Goldschlager, N. Torsades de pointes during administration of pentamidine isethionate. Am. J. Med., 83, 571, 1987
Harel, Y., Scott, W. A., Szeinberg, A., and Barzilay, Z. Pentamidine-induced torsades de pointes. Pediatr. Infect. Dis. J., 12, 692, 1993.
Green, P. T., Reents, S., Harman, F., and Curtis, A. B. Pentamidine-induced torsades de pointes in a renal transplant recipient with Pneumocystis carinii pneumonia. South. Med. J., 83, 481, 1990.
Mitchell, P., Dodek, P., Lawson, L., Kiess, M., and Russell, J. Torsades de pointes during intravenous pentamidine isethionate therapy. Can. Med. Assoc. J., 140, 173, 1989.
Hancock, E. W. Possible torsade in a patient with AIDS. Hosp. Pract., 25, 132, 1990.
Engrav, M. B., Coodley, G., and Magnusson, A. R. Torsades de pointes after inhaled pentamidine. Ann. Emerg. Med., 21, 1404, 1992.
Vukmir, R. B. Torsades de pointes: a review. Am. J. Emerg. Med., 9, 250, 1991.
Stein, K. M., Haronian, H., Mensah, G. A., Acosta, A., Jacobs, J., and Kligfield, P. Ventricular tachycardia and torsades de pointes complicating pentamidine therapy of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Am. J. Cardiol., 66, 888, 1990.
Miller, H. C. Cardiac arrest after intravenous pentamidine in an infant. Pediatr. Infect. Dis. J., 12, 694, 1993.
Tzivoni, D., Keren, A., Cohen, A. M., et al. Magnesium therapy for torsades de pointes. Am. J. Cardiol., 53, 528, 1984.
Sasyniuk, B. I., Valois, M., and Toy, W. Recent advances in understanding the mechanisms of drug-induced torsades de pointes arrhythmias. Am. J. Cardiol., 64, 29J, 1989.
Pais, J. R., Cazorla, C., Novo, E., and Viana, A. Massive haemorrhage from rupture of a pancreatic pseudocyst after pentamidine-associated pancreatitis. Eur. J. Med., 1, 251, 1992.
Mandrell, B. N. and McCormick, J. N. Dapsone-induced methemoglobinemia in pediatric oncology patients: case examples. J. Pediatr. Oncol. Nurs., 18, 224–228, 2001.
DeGowin, R. L., Eppes, B., Powell, R. D., and Carson, P. E. The haemolytic effects of diphenylsulfone (DDS) in normal subjects and in those with glucose-6-phosphate-dehydrogenase deficiency. Bull. WHO, 35, 165, 1966.
Metroka, C. E., Lewis, N. J., and Jacobus, D. P. Desensitization to dapsone in HIV-positive patients. J. Am. Med. Assoc., 267, 512, 1992.
Freund, Y. R., Dousman, L., Riccio, E. S., Sato, B., MacGregor, J. T., and Mohagheghpour, N. Immunohematotoxicity studies with combinations of dapsone. Int. Immunopharmacol., 1, 2131–2141, 2001.
Kluge, R. M., Spaulding, D. M., and Spain, A. J. Combination of pentamidine and trimethoprim-sulfamethoxazole in the therapy of Pneumocystis carinii pneumonia in rats. Antimicrob. Agents Chemother., 13, 975, 1978.
Hughes, W. T., McNabb, P. C., Makres, T. D., and Feldman, S. Efficacy of trimethoprim and sulfamethoxazole in the prevention and treatment of Pneumocystis carinii pneumonitis. Antimicrob. Agents Chemother., 5, 289, 1974.
Hughes, W. T. and Smith, B. L. Efficacy of diaminodiphenylsulfone and other drugs in murine Pneumocystis carinii pneumonitis. Antimicrob. Agents Chemother., 26, 436, 1984.
Frenkel, J. K., Good, J. T., and Shultz, J. A. Latent Pneumocystis infection of rats, relapse and chemotherapy. Lab. Invest., 15, 1559, 1966.
Queener, S. F., Bartlett, M. S., Durkin, M. M., Jay, M. A., and Smith, J. W. Activity of clindamycin with primaquine toward Pneumocystis carinii in vitro and in vivo. Proc. 27th Intersci. Conf. Antimicrob. Agents Chemother., American Society for Microbiology, Washington, DC, abstract 574, 1987.
Hughes, W. T. and Killmar, J. T. Synergistic anti-Pneumocystis carinii effects of erythromycin and sulfisoxazole. J. Acquir. Immune Defic. Syndr., 4, 523, 1991.
Walzer, P. D., Foy, J., Steele, P., and White, M. Synergistic combinations of Ro 11–8958 and other dihydrofolate reductase inhibitors with sulfamethoxazole and dapsone for therapy of experimental pneumocystosis. Antimicrob. Agents Chemother., 37, 1436, 1993.
U.S. Public Health Service Task Force on anti-pneumocystis prophylaxis in patients with human immunodeficiency virus infection: recommendation for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. J. Acquir. Immune Defic. Syndr., 6, 46, 1993.
Hardy, W. D., Feinberg, J., Finkelstein, D. M., et al. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome (AIDS clinical trial group protocol 021). N. Engl. J. Med., 327, 1842, 1992.
Arico, M., Molinari, E., Bacchella, L., DeAmici, M., Raiteri, E., and Burgio, G. R. Prospective randomized comparison of toxicity of two prophylactic regimens of cotrimoxazole in leukemic children. Pediatr. Hematol. Oncol., 9, 35, 1992.
Badri, M., Ehrlich, R., Wood, R., and Maartens, G. Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO/UNAIDS recommendation. AIDS, 15, 1143–1148, 2001.
Stearn, B. F. and Polis, M. A. Prophylaxis of opportunistic infections in persons with HIV infection. Cleve. Clin. J. Med., 61, 187, 1994.
Nielsen, T. L., Jensen, B. N., Nelsing, S., et al. Prevention of Pneumocystis carinii pneumonia relapse in AIDS patients: the efficacy and tolerability of low-dose sulfamethoxazole-trimethoprim. Dan. Med. Bull., 40, 503, 1993.
Smulders, Y. M., Spoelstra-de Man, A. M., Slaats, E. H., Weigel, H. M., Stehouwer, C. D., and Jos Frissen P. H. Trimethoprim-sulphamethoxazole as primary Pneumocystis carinii prophylaxis does not increase serum homocysteine levels in HIV-positive subjects. Eur. J. Intern. Med., 12, 363–365, 2001.
Gifford, A. L., McPhee, S. J., and Fordham, D. Preventive care among HIV-positive patients in a general medicine practice. Am. J. Prey. Med., 10, 5, 1994.
Longini, I. M. Jr., Clark, W. S., and Karon, J. M. Effect of routine use of therapy in slowing the clinical course of human immunodeficiency virus (HIV) infection in a population-based cohort. Am. J. Epidemiol., 137, 1229, 1993.
Chaisson, R. E., Keruly, J., Richman, D. D., and Moore, R. D. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. Arch. Intern. Med., 152, 2009, 1992.
Graham, N. M., Zeger, S. L., Park, L. P., et al. The effects on survival of early treatment of human immunodeficiency virus infection. N. Engl. J. Med., 326, 1037, 1992.
Mazur, H. Prophylaxis and therapy for Pneumocystis pneumonia: where are we? Infect. Agents Dis., 1, 270, 1992.
Dworkin, M. S., Williamson, J., Jones, J. L., Kaplan, J. E. Adult and Adolescent Spectrum of HIV Disease Project. Clin. Infect. Dis., 33, 393–398, 2001.
Kovacs, J. A., Gill, V. J., Meshnick, S., and Masur, H. New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia. J. Am. Med. Assoc., 286, 2450–2460, 2001.
Trikalinos, T. A. and Ioannidis, J. P. Discontinuation of Pneumocystis carinii prophylaxis in patients infected with human immunodeficiency virus: a meta-analysis and decision analysis. Clin. Infect. Dis., 33, 1901–1909, 2001.
Ivez, N. J., Gazzard, B. G., and Esterbrook, P. J. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART) in a London clinic. J. Infect., 42, 134–139, 2001.
Urschel, S., Schuster, T., Dunsch, D., Wintergerst, U., Hofstetter, R., and Belohradsky, B. H. Discontinuation of primary Pneumocystis carinii prophylaxis after reconstitution of CD4 cell counts in HIV-infected children. AIDS, 15, 1589–1591, 2001.
Koletar, S. L., Heald, A. E., Finkelstein, D., et al. The ACTG 888 Study Team, A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to 200 x 106 /1. AIDS, 15, 1509–1515, 2001.
Le Moal, G., Breux, J. P., and Roblot, F. Discontinuing prophylaxis against Pneumocystis carinii pneumonia. N. Engl. J. Med., 344, 1639–1641, 2001.
U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA). 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. Infect Dis. Obstet. Gynecol., 8, 5–74, 2000.
Furrer, H., Egger, M., Opravil, M., et al. Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. N. Engl. J. Med., 340, 1301–1306, 1999.
Weverling, G. J., Mocroft, A., Lederberger, B., et al. Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. Lancet, 353, 1293–1298, 1999.
Schneider, M. M. E., Borlefs, J. C. C., Stolk, R. P., Jaspers, C. A. J. J., and Hoepelman, A. I. M. Discontinuation of Pneumocystis carinii pneumonia prophylaxis in HIV-1 infected patients treated with highly active retroactive therapy. Lancet, 353, 201–203, 1999.
Dworkin, M., Hanson, D., Jones, J., Kaplan, J., and the Adult/Adolescent Spectrum of HIV Disease Project (ASD). The risk for Pneumocystis carinii pneumonia (PCP) and disseminated non-tuberculous mycobacteriosis (dMb) after an antiretroviral therapy (ART) associated increase in the CD’ T-lymphocyte count. 6th Conf Retroviruse Opport. Infect., abstract no. 692, 1999.
Lopez, J. C., Pena, J. M., Miro, J. M., Podzamczer, D., and the GESIDA 04/98 Study Group. Discontinuation of PCP prophylaxis (PRO) is safe in HIV-infected patients (PTS) with immunological recovery with HAART. Preliminary results of an open, randomized and multicenter clinical trial (GESIDA 04/98). 6th Conf. Retroviruse Opport. Infect., abstract no. LB7, 1999.
Lim, L., Street, A. C., and Lewin, S. R. Pneumocystis carinii pneumonia after cessation of secondary prophylaxis in a patient on highly active antiretroviral therapy with a CD4 cell count greater than 200/mm3. AIDS, 15, 1912–1913, 2001.
Wislez, M., Bergot, E., Antoine, M., et al. Acute respiratory failure following HAART introduction in patients treated for Pneumocystis carinii pneumonia. Am. J. Respir. Crit. Care Med., 164, 847–851, 2001.
Gonzalez-Castillo, J., Blanco, F., Soriano, V., et al. Opportunistic episodes in patients infected with the human immunodeficiency virus during the first 6 months of HAART. Med. Clin. (Barc.), 117, 81–84, 2001.
Hauser, P. M., Sudre, P., Nahimana, A., Francioli, P. The Study Group, Clin. Infect. Dis., Prophylaxis failure is associated with a specific Pneumocystis carinii genotype. Clin. Infect. Dis., 33, 1080–1082, 2001.
Hamilton, J. D., Hartigan, P. M., Simberkoff, M. S., et al. A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection: results of the Veteran Affairs Cooperative Study. N. Engl. J. Med., 326, 437, 1992.
Hirschel, B. Early zidovudine and survival in HIV infection. N. Engl. J. Med., 327, 814, 1992.
Hartigan, P. M., Hamilton, J. D., and Simberkoff, M. S. Early zidovudine and survival in HIV patients. N. Engl. J. Med., 327, 815, 1992.
Gail, M. H. and Mark, S. D. Early zidovudine and survival in HIV infection. N. Engl. J. Med., 327, 815, 1992.
Asch, S. M., Gifford, A. L., Bozzette, S. A., et al. Underuse of primary Mycobacterium avium complex and Pneumocystis carinii prophylaxis in the United States. J. Acquir. Immune Defic. Syndr., 28, 340–344, 2001.
Castagnola, E., Zarri, D., Caprino, D., Losurdo, G., and Micalizzi, C. Cotrimoxazole prophylaxis of Pneumocystis carinii infection during the treatment of childhood acute lymphoblastic leukemia–beware non compliance in older children and adolescents. Support Care Cancer, 9, 552–553, 2001.
MacGregor, R. R., Morgan, A. S., Graziani, A. L., et al. Efficacy and tolerance of intermittent versus daily cotrimoxazole for PCP prophylaxis in HIV-positive patients. Am. J. Med., 92, 227, 1992.
Leoung, G. S., Stanford, J. F., Giordano, M. F., et al. American Foundation for AIDS Research (amfAR) Community-Based Clinical Trials Network. J. Infect. Dis., 184, 992–997, 2001.
Metroka, C. E., Jacobus, D. P., and Lewis, N. J. Successful chemoprophylaxis for Pneumocystis with dapsone or bactrim. Proc. 5th Int. Conf. AIDS, Montreal, abstract TB04, 1989.
Kemper, C. A., Tucker, R. M., Lang, O. S., et al. Low-dose dapsone prophylaxis of Pneumocystis carinii pneumonia in AIDS and AIDS-related complex. AIDS, 4, 1145, 1990.
Hughes, W. T., Kennedy, W., Dugdale, M., et al. Prevention of Pneumocystis carinii pneumonitis in AIDS patients with weekly dapsone. Lancet, 336, 1066, 1990.
Benedetti-Bardet, C., Guy, C., Boudignat, O., Regnier-Zerbib, A., 011agnier, M. Centres Regionaux de Pharmacovigilance, Adverse effects of disulone: results of the France pharmacovigilance inquiry, Regional centers of Pharmacovigilance. Therapie, 56, 295–299, 2001.
Blum, R. N., Miller, L. A., Gaggini, L. C., and Cohn, D. L. Comparative trial of dapsone versus trimethoprim/sulfamethoxazole for primary prophylaxis of Pneumocystis carinii pneumonia. J. Acquir. Immune Defic. Syndr., 5, 341, 1992.
Podzamczer, D., Santin, M., Jimenez, J., Casanova, A., Bolao, F., and Guidol, G. P. Thrice-weekly cotrimoxazole is better than weekly dapsone-pyrimethamine for the primary prevention of Pneumocystis carinii pneumonia in HIV-infected patients. AIDS, 7, 501, 1993.
Girard, P. M., Landman, R., Gaudebout, C., et al. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. N. Engl. J. Med., 328, 1514, 1993.
Koppen, S., Grunewald, T., Jautzke, G., Gottschalk, J., Pohle, A. D., and Ruf, B. Prevention of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus infected patients: a clinical approach comparing aerosolized pentamidine and pyrimethamine/sulfadoxine. Clin. Invest., 70, 508, 1992.
Jensen, B. N., Nielsen, T. L., Backer, V., et al. Aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a controlled, randomized trial. J. Acquir. Immune Defic. Syndr., 6, 472, 1993.
Ong, E. L., Dunbar, E. M., and Mandai, B. K. Efficacy and effects on pulmonary function tests of weekly 600 mg aerosol pentamidine as prophylaxis against Pneumocystis carinii pneumonia. Infection, 20, 136, 1992.
Tullis, E., Yu, D. G., Rawji, M., Rachlis, A., Hyland, R., and Chan, C. K. The long-term effects of aerosol pentamidine on pulmonary function: the Toronto Aerosolized Pentamidine Study (TAPS) Group. Clin. Invest. Med., 15, 42, 1992.
O’Sullivan, B. P. and Spaulding, R. The use of aerosolized pentamidine for prophylaxis of Pneumocystis carinii pneumonia in children with leukemia. Pediatr. Pulmonol., 18, 228, 1994.
Güngör, T., Funk, M., Linde, R., et al. Combined therapy in human immunodeficiency virus-infected children: a 4-year experience. Eur. J. Pediatr., 152, 650, 1993.
Rigaud, M., Pollack, H., Leibovitz, E., et al. Efficacy of primary chemoprophylaxis against Pneumocystis carinii pneumonia during the first year of life in infants affected with human immunodeficiency virus type 1. J. Pediatr., 125, 476, 1994.
Mallolas, J., Zamora, L., Gatell, J. M., et al. Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine. AIDS, 7, 59, 1993.
Gutteridge, W. E. 556C80, an antimalarial hydroxynaphthoquinone with broad spectrum: experimental activity against opportunistic parasitic infections of AIDS patients. J. Protozool., 38, 1418, 1991.
Hudson, A. T., Dickins, M., Ginger, C. D., et al. 566C80: a potent broad spectrum anti-infective agent with activity against malaria and opportunistic infections in AIDS patients. Drugs Exptl. Clin. Res., 17, 427, 1991.
Hughes, W. T., Gray, V. L., Gutteridge, W. E., Latter, V. S., and Pudney, M. Efficacy of a hydroxynaphthoquinone, 566C80, in experimental Pneumocystis carinii pneumonits. Antimicrob. Agents Chemother., 34, 225, 1990.
Meyers, B., Borrego, F., and Papanicolaou, G. Pneumocystis carinii pneumonia prophylaxis with atovaquone in trimethoprim-sulfamethoxazole-intolerant orthotopic liver transplant patients: a preliminary study. Liver Transpl., 7, 750–751, 2001.
Schroder, H., Agger, K. E., Rosthoj, S., Carlsen, N. T., and Schmiegelow, K. Antibacterial prophylaxis with trimethoprim-sulfamethoxazole during induction treatment for acute lymphoblastic leukemia. Dan. Med. Bull., 48, 275–277, 2001.
Fisher, R. G., Nageswaran, S., Valentine, M. E., and McKinney, R. E., Jr. Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprimsulfamethoxazole. AIDS Patient Care, 15, 263–269, 2001.
Slivka, A., Wen, P. Y., Shea, W. M., and Loeffler, J. S. Pneumocystis carinii pneumonia during steroid taper in patients with primary brain tumors. Am. J. Med., 94, 216, 1993.
Seymour, J. F., Grigg, A. P., Szer, J., and Fox, R. M. Fludarabine and mitoxanthrone: effective and well-tolerated salvage therapy in relapsed indolent lymphoproliferative disorders. Ann. Oncol., 12, 1455–1460, 2001.
Murphy, J. L., Kano, H. L., Chenaille, P. J., and Makker, S. P. Fatal Pneumocystis pneumonia in a child treated for focal segmental glomerulosclerosis. Pediatr. Nephrol., 7, 444, 1993.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Georgiev, V.S. (2003). Pneumocystis carinii. In: Opportunistic Infections. Infectious Disease. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-296-8_35
Download citation
DOI: https://doi.org/10.1007/978-1-59259-296-8_35
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-303-9
Online ISBN: 978-1-59259-296-8
eBook Packages: Springer Book Archive